Flosequinan

This classification denotes a vasodilating agent with the molecular formula C11H10FNO2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6NB119DLU7, chemically known as 4(1h)-quinolinone, 7-fluoro-1-methyl-3-(methylsulfinyl)- but generally known as flosequinan, which bears US NIH Compound Identifier 53516. European Medicines Agency schedules Flosequinan in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07654MIG. The term FLOSEQUINAN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 1, No. 4, 1987, List 27). World Health Organization schedules flosequinan in its Anatomical Therapeutic Chemical (ATC) Classification. FLOSEQUINAN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule flosequinan under HS 29334990 and SITC 51575. As of Q4 2014, FLOSEQUINAN remains the US FDA Preferred Term for this commodity. Flosequinan bears US NLM identifiers UMLS ID C0060470 and NCI Concept Code C73109. SMILES: CN1C=C(C(=O)C2=C1C=C(C=C2)F)SOC.